CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | Nash Huw M. COO & CBO | Sale | −15,995 | $26.37 | $422K | 0 |
| 2020-03-02 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −6,324 | 146,000 | ||
| 2020-03-02 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −42,779 | 230,818 | ||
| 2019-12-20 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion · Employee Stock Option (right to buy) | −6,000 | 149,066 | ||
| 2019-12-20 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion | +6,000 | $0.60 | $4K | 6,000 |
| 2019-12-20 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion · Employee Stock Option (right to buy) | +6,000 | 149,066 | ||
| 2019-12-16 | Kaye Edward M. MD CEO | Exercise or conversion · Employee Stock Option (right to buy) | −50,000 | 647,801 | ||
| 2019-12-16 | Kaye Edward M. MD CEO | Exercise or conversion | +50,000 | $0.60 | $30K | 50,000 |
| 2019-12-16 | Kaye Edward M. MD CEO | Exercise or conversion · Employee Stock Option (right to buy) | +50,000 | 647,801 | ||
| 2019-11-15 | Walker Robin A. Chief Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +84,800 | 84,800 | ||
| 2019-11-08 | RTW INVESTMENTS, LP 10% owner | Sale | −16,434 | $28.70 | $472K | 3,544,248 |
| 2019-11-04 | RTW INVESTMENTS, LP 10% owner | Purchase | +104,873 | $29.24 | $3.1M | 3,560,682 |
| 2019-11-01 | RTW INVESTMENTS, LP 10% owner | Purchase | +8,598 | $28.61 | $246K | 3,455,809 |
| 2019-10-31 | RTW INVESTMENTS, LP 10% owner | Purchase | +18,747 | $28.15 | $528K | 3,447,211 |
| 2019-10-30 | RTW INVESTMENTS, LP 10% owner | Purchase | +41,438 | $28.79 | $1.2M | 3,428,464 |
| 2019-10-01 | RTW INVESTMENTS, LP 10% owner | Purchase | +31,560 | $21.96 | $693K | 3,387,026 |
| 2019-09-10 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2019-09-10 | Hall Samuel W. Director | Grant or award · Director Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2019-09-10 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2019-09-10 | TZIANABOS ARTHUR Director | Grant or award · Director Stock Option (Right to Buy) | +14,777 | 14,777 |
Page 33 of 35 · 681 trades